* Helius Medical Technologies Inc HSDT.OQ HSDT.O is
expected
to show a fall in quarterly revenue when it reports results on
August 8 (estimated) for the period ending June 30 2024
* The Newtown Pennsylvania-based company is expected to
report a
41.4% decrease in revenue to $150 thousand from $256 thousand a
year ago, according to the estimate from one analyst, based on
LSEG data.
* LSEG's mean analyst estimate for Helius Medical
Technologies
Inc is for a loss of 50 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Helius
Medical
Technologies Inc is $4.00, above its last closing price
of $0.66.
This summary was machine generated August 6 at 11:49 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)